Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma

We evaluated the response to and toxicity of allogeneic or autologous bone marrow transplantation (BMT) for patients with non-Hodgkin's lymphoma (NHL) who relapsed after autologous BMT. Since 1990, 172 patients have received autologous BMTs in NHL at the MD Anderson Cancer Center and 75 have re...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 1997-01, Vol.19 (2), p.121-127
Hauptverfasser:	DE LIMA, M, VAN BESIEN, K. W, GIRALT, S. A, KHOURI, I. F, MEHRA, R, ANDERSSON, B. S, PRZEPIORKA, D, GAJEWSKI, J. L, KORBLING, M, CHAMPLIN, R. E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Autografts Biological and medical sciences Blood Bone marrow Bone Marrow Transplantation Bone marrow, stem cells transplantation. Graft versus host reaction Busulfan Cyclophosphamide Etoposide Fatalities Female Hematopoietic stem cells Humans Irradiation Lymphoma Lymphoma, Non-Hodgkin - pathology Lymphoma, Non-Hodgkin - therapy Male Medical sciences Melphalan Middle Aged Non-Hodgkin's lymphoma Patients Peripheral blood Radiation Recurrence Retrospective Studies Stem cell transplantation Stem cells Toxicity Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation, Autologous Transplantation, Homologous Transplants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!